| | Identification | Back Directory |  | [Name] 
 6-METHYLPURINE RIBOSIDE
 |  | [CAS] 
 14675-48-0
 |  | [Synonyms] 
 6-D-MPR
 Nsc101619
 6-METHYLPURINE RIBOSIDE
 6-Methylpurine-β-D-riboside
 6-Methylpurine ribonucleoside
 6-Methylpurine-beta-D-riboside
 6-Methylpurine-9-beta-D-ribofuranoside
 6-Methyl-9.beta.-D-ribofuranosylpurine
 6-Methyl-9-(1-β-D-ribofuranosyl)purine
 9H-Purine, 6-methyl-9-b-D-ribofuranosyl-
 9H-Purine, 6-methyl-9-β-D-ribofuranosyl-
 6-Methyl-9-(beta-D-ribofuranosyl)-9H-purine
 9H-Purine, 6-methyl-9-.beta.-D-ribofuranosyl-
 (2R,3S,4R,5R)-2-(HydroxyMethyl)-5-(6-Methyl-9H-purin-9-yl)tetrahydrofuran-3,4-diol
 (2r,3s,4r,5r)-2-(hydroxymethyl)-5-(6-methyl-1H-purin-9-yl)tetrahydrofuran-3,4-diol
 |  | [Molecular Formula] 
 C11H14N4O4
 |  | [MDL Number] 
 MFCD00056009
 |  | [MOL File] 
 14675-48-0.mol
 |  | [Molecular Weight] 
 266.25
 | 
 | Chemical Properties | Back Directory |  | [Melting point ] 
 209-210 °C
 |  | [Boiling point ] 
 590.4±60.0 °C(Predicted)
 |  | [density ] 
 1.81±0.1 g/cm3(Predicted)
 |  | [storage temp. ] 
 Sealed in dry,Store in freezer, under -20°C
 |  | [form ] 
 Solid
 |  | [pka] 
 13.13±0.70(Predicted)
 |  | [color ] 
 White to off-white
 |  | [InChI] 
 InChI=1/C11H14N4O4/c1-5-7-10(13-3-12-5)15(4-14-7)11-9(18)8(17)6(2-16)19-11/h3-4,6,8-9,11,16-18H,2H2,1H3/t6-,8-,9-,11-/s3
 |  | [InChIKey] 
 FIGBCBGMUIGJBD-SOMIAQKHNA-N
 |  | [SMILES] 
 N1(C=NC2C(C)=NC=NC1=2)[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 |&1:10,11,13,15,r|
 | 
 | Hazard Information | Back Directory |  | [Description] 
 6-Methylpurine-β-D-riboside (β-D-MPR; 6-methylpurine riboside), an antibiotic isolated from culture broths of the basidiomycetes fungi Collybia dryophilia and Collybia maculata, has antifungal, antiviral and antitumor activity. β-D-MPR is an excellent substrate of mammalian adenosine deaminase (ADA), and its mechanism of activation in tumor cells presumably relates to its interaction with this enzyme [1].
 |  | [Uses] 
 6-Methylpurine riboside is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
 |  | [References] 
 [1] Sufrin, J . "Improved Synthesis of β-D-6-Methylpurine Riboside and Antitumor Effects of the β-D- and α-D-Anomers." Molecules 10(2005).
 | 
 | 
                    
                        
                            | Company Name: | T&W GROUP |  
                            | Tel: | 021-61551611 13296011611 |  
                            | Website: | www.trustwe.com/ |  |